Rare Variation and Remote Gene Regulation of Osteoporosis Related Phenotypes in Han Chinesse

Senile Osteoporosis With Current Pathological Fracture Lower Leg (Diagnosis) Clinical Trial

Official title:

Rare Variation and Remote Gene Regulation of Osteoporosis Related Phenotypes in Han Chinesse

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04129671
• Other study ID #: 2018-090
• Status: Recruiting
• Start date: April 29, 2019
• Est. completion date: December 31, 2021

Study information

• Verified date: October 2019
• Source: Second Affiliated Hospital, School of Medicine, Zhejiang University
• Contact: Shigui Yan, Doctore
• Phone: 057187783530
• Email: Olivery[@]zju.edu.cn
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Bone density is recognized as the most important factor to measure osteoporosis, and the prevalence of osteoporosis increases with age. Risk factors for osteoporosis include age, weight, exercise, diet, smoking and alcohol consumption. What's more, osteoporosis has a strong familial aggregation, and the genetic value of bone density is between 0.6 and 0.85. Therefore, it is necessary to conduct large-scale collection of population samples of osteoporosis fractures and relevant genetic studies.

Description:

From past linkage analysis and candidate gene association studies to genome-wide association studies and second-generation sequencing technologies, researchers have found hundreds of genes and SNPs associated with bone mineral density and osteoporosis fractures. However, current studies on osteoporosis and related phenotypes are mainly concentrated in the European and American populations, rare in Asia and other regions, and even less in the Chinese han population. It is one of the problems to be solved in this project whether the genes and SNP loci associated with these strengths can also be applied to han Chinese population due to the existence of racial differences. This project aims to collect the patients with primary osteoporosis and osteoporosis fracture in the Chinese han population through the orthopaedics department, and verify the identified osteoporosis susceptibility genes in the Chinese han population.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 3000
• Est. completion date: December 31, 2021
• Est. primary completion date: December 1, 2021
• Gender: All
• Age group: 50 Years to 100 Years

Eligibility

Inclusion Criteria:

1. From July 2018 to July 2021, patients admitted to the outpatient or inpatient clinic were diagnosed as primary osteoporosis fracture;

2. Aged between 50 and 100;

3. This fracture was not treated with any anti-osteoporosis drugs before

4. Subjects will participate in the study voluntarily and have signed the informed consent

5. Patients with clear mind and independent behavioral ability

Exclusion Criteria:

1. Patients with malignant tumors are associated with bone metastases, such as lung cancer, prostate cancer, thyroid cancer, etc

2. Hyperparathyroidism, Cushing syndrome, hypogonadism, hyperthyroidism, pituitary prolactinoma, diabetes

3. Systemic lupus erythematosus, rheumatoid arthritis, sjogren's syndrome, dermatomyositis, mixed connective tissue disease, etc.;

4. Renal osteodystrophy caused by various chronic kidney diseases;

5. Gastrointestinal diseases and nutritional diseases: malabsorption syndrome, subtotal gastrectomy, chronic pancreatic diseases, chronic liver diseases, protein-calorie malnutrition, long-term intravenous nutrition support treatment, etc.;

6. Leukemia, lymphoma, multiple myeloma, hyperthermia and myelodysplastic syndrome;

7. Hemiplegia, paraplegia, motor dysfunction, muscular dystrophy, catalepsy and myotonic syndrome caused by various reasons;

8. Glucocorticoids, immunosuppressants, heparin, anticonvulsants, anticancer drugs, aluminum-containing antacids, thyroid hormones, gnrh-a or dialysate, etc.

9. Unwilling to accept dietary management or unable to sign the informed consent

Related Conditions & MeSH terms

• Osteoporosis
• Senile Osteoporosis With Current Pathological Fracture Lower Leg (Diagnosis)

Intervention

Genetic:
• No intervention was applied
No intervention was administered

Locations

Country	Name	City	State
China	2nd Affiliated Hospital, School of Medicine, Zhejiang University, China	Hangzhou	Zhejing Province

Sponsors (2)

Lead Sponsor	Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University	Westlake University

Country where clinical trial is conducted

China, 

References & Publications (2)

He W, Liu M, Huang X, Qing Z, Gao W. The influence of vitamin D receptor genetic variants on bone mineral density and osteoporosis in Chinese postmenopausal women. Dis Markers. 2015;2015:760313. doi: 10.1155/2015/760313. Epub 2015 Feb 17. — View Citation

Mendoza N, Quereda F, Presa J, Salamanca A, Sánchez-Borrego R, Vázquez F, Martínez Astorquiza T. Estrogen-related genes and postmenopausal osteoporosis risk. Climacteric. 2012 Dec;15(6):587-93. doi: 10.3109/13697137.2012.656160. Epub 2012 Feb 15. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Exon sequencing results from the target region	Exon sequencing	June 2018-December 2021